Treatment for hypertension, male in Europe & Central Asia (IDA & IBRD countries)
Europe & Central Asia (IDA & IBRD countries): Treatment for hypertension, male was 44.4% in 2019. ▲ Rising
Treatment for hypertension, male in Europe & Central Asia (IDA & IBRD countries), 1990–2019
Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of male adults ages 30-79 with hypertension.
Analysis
In 2019, treatment for hypertension, male in Europe & Central Asia (IDA & IBRD countries) stood at 44.4%. That is the highest value across all 30 years on record.
That represents a change of up 1.7% on the previous year and up 24.0% over ten years.
Over the whole period, treatment for hypertension, male in Europe & Central Asia (IDA & IBRD countries) peaked at 44.4% in 2019 and was at its lowest, 16.5%, in 1990.
That places Europe & Central Asia (IDA & IBRD countries) 12th out of 43 groups with data for 2019, putting it in the middle of the range.
The long-run direction has been consistently rising across the 30 years of available data.
Treatment for hypertension, male in Europe & Central Asia (IDA & IBRD countries), year by year
| Year | % of male adults ages 30-79 with hypertension | Change |
|---|---|---|
| 1990 | 16.5% | — |
| 1991 | 17.2% | +4.6% |
| 1992 | 18.1% | +4.7% |
| 1993 | 19.0% | +5.0% |
| 1994 | 19.9% | +4.9% |
| 1995 | 20.9% | +5.0% |
| 1996 | 21.9% | +4.9% |
| 1997 | 22.9% | +4.7% |
| 1998 | 23.9% | +4.4% |
| 1999 | 25.0% | +4.5% |
| 2000 | 26.1% | +4.3% |
| 2001 | 27.1% | +4.1% |
| 2002 | 28.3% | +4.1% |
| 2003 | 29.4% | +3.9% |
| 2004 | 30.5% | +3.8% |
| 2005 | 31.6% | +3.6% |
| 2006 | 32.7% | +3.4% |
| 2007 | 33.7% | +3.2% |
| 2008 | 34.8% | +3.1% |
| 2009 | 35.8% | +2.9% |
| 2010 | 36.8% | +2.7% |
| 2011 | 37.8% | +2.7% |
| 2012 | 38.7% | +2.6% |
| 2013 | 39.6% | +2.3% |
| 2014 | 40.5% | +2.1% |
| 2015 | 41.3% | +2.1% |
| 2016 | 42.1% | +2.0% |
| 2017 | 42.9% | +1.7% |
| 2018 | 43.6% | +1.8% |
| 2019 | 44.4% | +1.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 20.5% | 16.5% | 25.0% | 10 |
| 2000s | 31.0% | 26.1% | 35.8% | 10 |
| 2010s | 40.8% | 36.8% | 44.4% | 10 |
Countries ranked near Europe & Central Asia (IDA & IBRD countries)
More health data for Europe & Central Asia (IDA & IBRD countries)
- Population ages 30-34, male, per capita 0.035 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.34 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0402 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate -0.0639 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0397 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate -0.1882 % change on previous year (2025)
- Population ages 25-29, male, per capita 0.0307 units per person (2025)
Frequently asked questions
- What is treatment for hypertension, male in Europe & Central Asia (IDA & IBRD countries)?
- Treatment for hypertension, male in Europe & Central Asia (IDA & IBRD countries) was 44.4% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
- What is the highest treatment for hypertension, male recorded in Europe & Central Asia (IDA & IBRD countries)?
- The highest recorded value was 44.4% in 2019.
- What is the lowest treatment for hypertension, male recorded in Europe & Central Asia (IDA & IBRD countries)?
- The lowest recorded value was 16.5% in 1990.
- How does Europe & Central Asia (IDA & IBRD countries) rank for treatment for hypertension, male?
- Europe & Central Asia (IDA & IBRD countries) ranks 12th out of 43 groups with data for 2019.
- Is treatment for hypertension, male rising or falling in Europe & Central Asia (IDA & IBRD countries)?
- Over the last ten years it is up 24.0%. The long-run trend across the full record is rising.
- Where does this Europe & Central Asia (IDA & IBRD countries) data come from?
- The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.